[1] « Syndrome des ovaires polykystiques (SOPK) ». Inserm - La science pour la santé. https://www.inserm.fr/information-en-sante/dossiers-information/syndrome-ovaires-polykystiques-sopk.
[2] « Women with Polycystic Ovary Syndrome at Significantly Increased Risk of COVID-19 ». 9 mars 2021. University of Birmingham. https://www.eurekalert.org/pub_releases/2021-03/uob-wwp030921.php.
[3] Randeva, Harpal S., Bee K. Tan, Martin O. Weickert, Konstantinos Lois, John E. Nestler, Naveed Sattar, et Hendrik Lehnert. 2012. « Cardiometabolic Aspects of the Polycystic Ovary Syndrome ». Endocrine Reviews 33 (5): 812‑41. https://doi.org/10.1210/er.2012-1003.
[4] Moran, Lisa J., Marie L. Misso, Robert A. Wild, et Robert J. Norman. 2010. « Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis ». Human Reproduction Update 16 (4): 347‑63. https://doi.org/10.1093/humupd/dmq001.
[5] Jin, Jian-Min, Peng Bai, Wei He, Fei Wu, Xiao-Fang Liu, De-Min Han, Shi Liu, et Jin-Kui Yang. 2020. « Gender Differences in Patients With COVID-19: Focus on Severity and Mortality ». Frontiers in Public Health 8. https://doi.org/10.3389/fpubh.2020.00152.
[6] La Vignera, Sandro, Rossella Cannarella, Rosita A. Condorelli, Francesco Torre, Antonio Aversa, et Aldo E. Calogero. 2020. « Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D ». International Journal of Molecular Sciences 21 (8): 2948. https://doi.org/10.3390/ijms21082948.
[7] Goren, Andy, Sergio Vaño-Galván, Carlos Gustavo Wambier, John McCoy, Alba Gomez-Zubiaur, Oscar M. Moreno-Arrones, Jerry Shapiro, et al. 2020. « A Preliminary Observation: Male Pattern Hair Loss among Hospitalized COVID-19 Patients in Spain - A Potential Clue to the Role of Androgens in COVID-19 Severity ». Journal of Cosmetic Dermatology 19 (7): 1545‑47. https://doi.org/10.1111/jocd.13443.
[8] Fagone, Paolo, Rosella Ciurleo, Salvo Danilo Lombardo, Carmelo Iacobello, Concetta Ilenia Palermo, Yehuda Shoenfeld, Klaus Bendtzen, Placido Bramanti, et Ferdinando Nicoletti. 2020. « Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies ». Autoimmunity Reviews 19 (7): 102571. https://doi.org/10.1016/j.autrev.2020.102571.
[9] Sirmans, Susan M, et Kristen A Pate. 2013. « Epidemiology, diagnosis, and management of polycystic ovary syndrome ». Clinical Epidemiology 6 (décembre): 1‑13. https://doi.org/10.2147/CLEP.S37559.
[10] Fagone, Paolo, Rosella Ciurleo, Salvo Danilo Lombardo, Carmelo Iacobello, Concetta Ilenia Palermo, Yehuda Shoenfeld, Klaus Bendtzen, Placido Bramanti, et Ferdinando Nicoletti. 2020. « Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies ». Autoimmunity Reviews 19 (7): 102571. https://doi.org/10.1016/j.autrev.2020.102571.
[11] Panarese, Alba, et Endrit Shahini. 2020. « Letter: Covid‐19, and vitamin D ». Alimentary Pharmacology & Therapeutics 51 (10): 993‑95. https://doi.org/10.1111/apt.15752.
[12] Ilie, Petre Cristian, Simina Stefanescu, et Lee Smith. 2020. « The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality ». Aging Clinical and Experimental Research, mai, 1‑4. https://doi.org/10.1007/s40520-020-01570-8.
[13] Hastie, Claire E., Daniel F. Mackay, Frederick Ho, Carlos A. Celis-Morales, Srinivasa Vittal Katikireddi, Claire L. Niedzwiedz, Bhautesh D. Jani, et al. 2020. « Vitamin D concentrations and COVID-19 infection in UK Biobank ». Diabetes & Metabolic Syndrome 14 (4): 561‑65. https://doi.org/10.1016/j.dsx.2020.04.050.
[14] Marik, Paul E., Pierre Kory, et Joseph Varon. 2020. « Does vitamin D status impact mortality from SARS-CoV-2 infection? » Medicine in Drug Discovery 6 (juin): 100041. https://doi.org/10.1016/j.medidd.2020.100041.
[15] Reis, Guilherme Victor Oliveira Pimenta Dos, Natália Alves Gontijo, Kathryna Fontana Rodrigues, Michelle Teodoro Alves, Cláudia Natália Ferreira, et Karina Braga Gomes. 2017. « Vitamin D Receptor Polymorphisms and the Polycystic Ovary Syndrome: A Systematic Review ». The Journal of Obstetrics and Gynaecology Research 43 (3): 436‑46. https://doi.org/10.1111/jog.13250.
[16] Azadi-Yazdi, Maryam, Azadeh Nadjarzadeh, Hossein Khosravi-Boroujeni, et Amin Salehi-Abargouei. 2017. « The Effect of Vitamin D Supplementation on the Androgenic Profile in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials ». Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme 49 (3): 174‑79. https://doi.org/10.1055/s-0043-103573.
[17] Kyrou, Ioannis, Emmanouil Karteris, Tim Robbins, Kamaljit Chatha, Fotios Drenos, et Harpal S. Randeva. 2020. « Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic ». BMC Medicine 18 (1): 220. https://doi.org/10.1186/s12916-020-01697-5.
[18] Zhang, Wen, Yan Zhao, Fengchun Zhang, Qian Wang, Taisheng Li, Zhengyin Liu, Jinglan Wang, et al. 2020. « The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China ». Clinical Immunology (Orlando, Fla.) 214 (mai): 108393. https://doi.org/10.1016/j.clim.2020.108393.
[19] Kyrou, Ioannis, Emmanouil Karteris, Tim Robbins, Kamaljit Chatha, Fotios Drenos, et Harpal S. Randeva. 2020. « Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic ». BMC Medicine 18 (1): 220. https://doi.org/10.1186/s12916-020-01697-5.